3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
74
Colorectal Neoplasms
43
Rectal Neoplasms
41
Stomach Neoplasms
38
Triple Negative Breast Neoplasms
30
Neoplasm Metastasis
19
Esophageal Neoplasms
16
Colonic Neoplasms
16
Pancreatic Neoplasms
12
Parkinson Disease 4, Autosomal Dominant Lewy Body
11
Neoplasms
11
Nasopharyngeal Carcinoma
11
Adenocarcinoma
11
Biliary Tract Neoplasms
10
Adenocarcinoma Of Esophagus
9
Cholangiocarcinoma
7
Locally Advanced Rectal Cancer
6
Esophageal Squamous Cell Carcinoma
6
Brain Neoplasms
6
Anus Neoplasms
6
Recurrence
5
Gastrointestinal Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Neuroendocrine Tumors
4
HER2-positive Breast Cancer
4
Colorectal Cancer Metastatic
4
Carcinoma, Non-Small-Cell Lung
4
Carcinoma, Hepatocellular
4
Advanced Solid Tumors
4
Pathologic Complete Response
3
Interventions
Cyclophosphamide
6
Vincristine
3
Temozolomide
3
Radiotherapy
3
Cisplatin
3
Automobiles
3
fludarabine
2
Etoposide
2
Eflornithine
2
Carboplatin
2
omburtamab I-131
1
ibrutinib
1
gallium Ga 68 dotatate
1
etoposide phosphate
1
belzutifan
1
Zoledronic Acid
1
Thiotepa
1
Tamoxifen
1
Standard of Care
1
Radiotherapy, Image-Guided
1
Pemetrexed
1
ONC206
1
Nivolumab
1
Mesna
1
Maintenance Chemotherapy
1
Lomustine
1
Isotretinoin
1
Induction Chemotherapy
1
Hydrocortisone
1
HhAntag691
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive
×
Capecitabine
×
1 year
×
Clear all
No trials found.